Dual-ligand effect of transferrin and transforming growth factor alpha on polyethyleneimine-mediated gene delivery

Journal of Controlled Release

Volumn 120, Issue 3, 2007, Pages 242-249

  Kakimoto, Shinji ^a   Moriyama, Tetsuji ^a   Tanabe, Toshizumi ^a   Shinkai, Seiji ^b   Nagasaki, Takeshi ^a  

^a Osaka Prefecture University   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Gene delivery; Non viral vector; Receptor mediated endocytosis; Transferrin; Transforming growth factor alpha

Indexed keywords

GENE DELIVERY; NON-VIRAL VECTORS; RECEPTOR-MEDIATED ENDOCYTOSIS; TRANSFERRIN; TRANSFORMING GROWTH FACTOR ALPHA;

CYTOLOGY; GENE TRANSFER; GROWTH KINETICS; LIGANDS; NITROGEN COMPOUNDS; VIRUSES;

PLASMA (HUMAN);

EPIDERMAL GROWTH FACTOR RECEPTOR; POLYETHYLENEIMINE; TRANSFERRIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; COMPLEX FORMATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOTINYLATION; CATTLE; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DNA; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; IMINES; LIGANDS; LUCIFERASES; MOLECULAR WEIGHT; POLYETHYLENES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, TRANSFERRIN; SERUM ALBUMIN, BOVINE; TRANSFECTION; TRANSFERRIN; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 34447340202     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.05.001     Document Type: Article

References (55)

1. Gatter K.C., Brown G., Trowbridge I.S., Woolston R.E., and Mason D.Y. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J. Clin. Pathol. 36 5 (1983) 539-545
2. Lloyd J.M., O'Dowd T., Driver M., and Tee D.E. Demonstration of an epitope of the transferrin receptor in human cervical epithelium-a potentially useful cell marker. J. Clin. Pathol. 37 2 (1984) 131-135
3. Raaf H.N., Jacobsen D.W., Savon S., and Green R. Serum transferrin receptor level is not altered in invasive adenocarcinoma of the breast. Am. J. Clin. Pathol. 99 3 (1993) 232-237
4. Recht L.D., Griffin T.W., Raso V., and Salimi A.R. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro. Cancer Res. 50 20 (1990) 6696-6700
5. Prost A.C., Menegaux F., Langlois P., Vidal J.M., Koulibaly M., Jost J.L., Duron J.J., Chigot J.P., Vayre P., Aurengo A., Legrand J.C., Rosselin G., and Gespach C. Differential transferrin receptor density in human colorectal cancer: a potential probe for diagnosis and therapy. Int. J. Oncol. 13 4 (1998) 871-875
6. Beguin Y., Lampertz S., De Groote D., Igot D., Malaise M., and Fillet G. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia 7 12 (1993) 2019-2025
7. Torp S.H., Helseth E., Dalen A., and Unsgaard G. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol. Immunother. 33 1 (1991) 61-64
8. Santini J., Formento J.L., Francoual M., Milano G., Schneider M., Dassonville O., and Demard F. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 13 2 (1991) 132-139
9. Rusch V., Mendelsohn J., and Dmitrovsky E. The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. Cytokine Growth Factor Rev. 7 2 (1996) 133-141
10. Cohen D.W., Simak R., Fair W.R., Melamed J., Scher H.I., and Cordon-Cardo C. Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues. J. Urol. 152 (1994) 2120-2124
11. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski Jr. V.R., and Kamen B.A. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52 12 (1992) 3396-3401
12. Wagner E., Zenke M., Cotten M., Beug H., and Birnstiel M.L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3410-3414
13. Lee H., Kim T.H., and Park T.G. A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor. J. Control. Release 83 (2002) 109-119
14. Sato Y., Yamauchi N., Takahashi M., Sasaki K., Fukaura J., Neda H., Fujii S., Hirayama M., Itoh Y., Koshita Y., Kogawa K., Kato J., Sakamaki S., and Niitsu Y. In vivo gene delivery to tumor cells by transferrin-streptavidin-DNA conjugate. FASEB J. 14 (2000) 2108-2118
15. Blessing T., Kursa M., Holzhauser R., Kircheis R., and Wagner E. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug. Chem. 12 (2001) 529-537
16. Grtcia-Espana A., Biria S., Malumbres M., Levin B., Meruelo D., and Pellicer A. Targeted gene transfer system using a streptavidin-transforming growth factor-alpha chimeric protein. DNA Cell Biol. 18 (1999) 743-749
17. Fominaya J., Uhereck C., and Wels W. A chimeric fusion protein containing transforming factor-α mediates gene transfer via binding to the EGF receptor. Gene Ther. 5 (1998) 521-530
18. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., and Finberg R.W. Isolation of a common receptor for Coxackie B viruses and adenoviruses 2 and 5. Science 275 (1997) 1320-1323
19. Wickham T.J., Mathias P., Cheresh D.A., and Nemerow G.R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73 (1993) 309-319
20. Green N.M. Avidin. Adv. Protein Chem. 29 (1975) 85-133
21. Iwamoto N., Shimamoto T., Kose S., Takao T., Tachibana T., Matsubae M., Sekimoto T., Shimonishi Y., and Yoneda Y. The nuclear pore-targeting complex binds to nuclear pores after association with a karyophile. FEBS Lett. 368 (1995) 415-419
22. Kose S., Iwamoto N., Tachibana T., Shimamoto T., and Yoneda Y. Ran-unassisted nuclear migration of a 97-kD component of nuclear pore-targeting complex. J. Cell Biol. 139 (1997) 841-849
23. Zhang Y., Zhu C., and Pardridge W.M. Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol. Ther. 6 (2002) 67-72
24. Zhang Y., Zhang Y.F., Bryant J., Charles A., Boado R.J., and Pardridge W.M. Intravenous RNA interderence gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin. Cancer Res. 10 (2004) 3667-3677
25. Sapra P., and Allen T.M. Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes. Clin. Cancer Res. 10 (2004) 2530-2537
26. Saul J.M., Annapragada A.V., and Bellamkonda R.V. A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J. Control. Release 114 (2006) 277-287
27. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7297-7301
28. Goustin A.S., Leof E.B., Shipley G.D., and Moses H.L. Growth factors and cancer. Cancer Res. 46 (1986) 1015-1029
29. Reddy C.C., Wells A., and Lauffenburger D.A. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha. J. Cell Physiol. 166 (1996) 512-522
30. Kircheis R., Wightman L., Schreiber A., Robitza B., Rossler V., Kursa M., and Wagner E. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8 (2001) 28-40
31. Lee H., Kim T.H., and Park T.G. A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor. J. Control. Release 83 (2002) 109-119
32. Widera A., Norouziyan F., and Shen W.C. Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery. Adv. Drug Deliv. Rev. 55 (2003) 1439-1466
33. Bao J., Alroy I., Waterman H., Schejter E.D., Brodie C., Gruenberg J., and Yarden Y. Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome. J. Biol. Chem. 275 (2000) 26178-26186
34. Klausner R.D., Van Renswoude J., Ashwell G., Kempf C., Schechter A.N., Dean A., and Bridges K.R. Receptor-mediated endocytosis of transferrin in K562 cells. J. Biol. Chem. 258 (1983) 4715-4724
35. Mulford C.A., and Lodish H.F. Endocytosis of the transferrin receptor is altered during differentiation of murine erythroleukemic cells. J. Biol. Chem. 263 (1988) 5455-5461
36. Penhallow R.C., Brown-Mason A., and Woodworth R.C. Comparative studies of the binding and growth-supportive ability of mammalian transferrins in human cells. J. Cell. Physiol. 128 (1986) 251-260
37. Brown P.M., Debanne M.T., Grothe S., Bergsma D., Caron M., Kay C., and O'Connor-McCourt M.D. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant. Eur. J. Biochem. 225 (1994) 223-233
38. Stromberg K., Collins IV T.J., Gordon A.W., Jackson C.L., and Johnson G.R. Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines. Cancer Res. 52 (1992) 341-347
39. Watson H., Franks S., and Bonney R.C. Characterization of epidermal growth factor receptor in human endometrial cells in culture. J. Reprod. Fertil. 101 (1994) 415-420
40. Caraglia M., Tagliaferri P., Correale P., Genua G., Pinto A., Del Vecchio S., Esposito G., and Bianco A.R. Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumor cells with anti-(growth factor receptor) mAb. Cancer Immunol. Immunother. 37 (1993) 150-156
41. Yanagihara K., Cheng H., and Cheng P.W. Effects of epidermal growth factor, transferrin, and insulin on lipofection efficiency in human lung carcinoma cells. Cancer Gene Ther. 7 (2000) 59-65
42. Rachwal W.J., Bongiorno P.F., Orringer M.B., Whyte R.I., Ethier S.P., and Beer D.G. Expression and activation of erbB-s and epidermal growth factor receptor in lung adenocarcinomas. Br. J. Cancer 72 (1995) 56-64
43. Kondo K., Noguchi M., Mukai K., Matsuno Y., Sato Y., Shimosato Y., and Monden Y. Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest 97 (1990) 1367-1371
44. Whitney J.F., Clark J.M., Griffin T.W., Gautam S., and Leslie K.O. Transferrin receptor expression in nonsmall cell cancer. Histophathologic and clinical correlates. Cancer 76 (1995) 20-25
45. Veale D., Ashcroft T., Marsh C., Gibson G.J., and Harris A.L. Epidermal growth factor receptors in non-small cell lung cancer. Br. J. Cancer 55 (1987) 513-516
46. Veale D., Kerr N., Gibson G.J., and Harris A.L. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res. 49 (1989) 1313-1317
47. Yamashiro D.J., Tycko B., Fluss S.R., and Maxfield F.R. Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the recycling pathway. Cell 37 (1984) 789-800
48. Jo M., Thomas K.S., Marozkina N., Amin T.J., Silva C.M., Parsons S.J., and Gonias S.L. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. J. Biol. Chem. 280 (2005) 17449-17457
49. Omary M.B., and Trowbridge I.S. Covalent binding of fatty acid to the transferrin receptor in cultured human cells. J. Biol. Chem. 256 (1981) 4715-4718
50. Trowbridge I.S., and Omary M.B. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 3039-3043
51. Collawn J.F., Lai A., Domingo D., Fitch M., Hatton S., and Trowbridge I.S. YTRF is the conserved internalization signal of the transferrin receptor, and a second YTRF signal at position 31-34 enhances endocytosis. J. Biol. Chem. 268 (1993) 21686-21692
52. Wu G.Y., and Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier systems. J. Biol. Chem. 262 (1987) 4429-4432
53. Wu G.Y., and Wu C.H. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263 (1988) 14621-14624
54. Cotton M., Laengle-Rouault F., Kirlappos H., Wagner E., Mechtler K., Zenke M., Beug H., and Birnstiel M.L. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferring receptor levels. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4033-4037
55. Ruponen M., Ylä-Herttuala S., and Urtti A. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim. Biophys. Acta 1415 (1999) 331-341